Degex Liquescence

Active substance: THUJA OCCIDENTALIS LEAFY TWIG, UBIDECARENONE, CONIUM MACULATUM FLOWERING TOP, ASTERIAS RUBENS, GERMANIUM, LACHESIS MUTA VENOM, BUFO BUFO CUTANEOUS GLAND, HUMAN BREAST TUMOR CELL, PHOSPHORUS

LIQUID · THUJA OCCIDENTALIS LEAFY TWIG 6 [hp_X]/mL, UBIDECARENONE 8 [hp_X]/mL, CONIUM MACULATUM FLOWERING TOP 9 [hp_X]/mL, ASTERIAS RUBENS 12 [hp_X]/mL, GERMANIUM 15 [hp_X]/mL, LACHESIS MUTA VENOM 12 [hp_X]/mL, BUFO BUFO CUTANEOUS GLAND 15 [hp_X]/mL, HUMAN BREAST TUMOR CELL 16 [hp_X]/mL, PHOSPHORUS 30 [hp_X]/mL

United StatesActive

Marketing holder: Nutritional Specialties, Inc.

Verified 2026-10-09 · openFDA NDC

Source: openFDA NDC
Countries with the substance registered: 1

Composition

THUJA OCCIDENTALIS LEAFY TWIG · 6 [hp_X]/mL
UBIDECARENONE · 8 [hp_X]/mL
CONIUM MACULATUM FLOWERING TOP · 9 [hp_X]/mL
ASTERIAS RUBENS · 12 [hp_X]/mL
GERMANIUM · 15 [hp_X]/mL
LACHESIS MUTA VENOM · 12 [hp_X]/mL
BUFO BUFO CUTANEOUS GLAND · 15 [hp_X]/mL
HUMAN BREAST TUMOR CELL · 16 [hp_X]/mL
PHOSPHORUS · 30 [hp_X]/mL

Registration

Registration number: 83027-0154
Registration status: Active
Dispensing: Over the counter
Route: ORAL

Sources

product · openFDA NDC · 83027-0154 · Verified 2026-10-09 · open in source
registration_status · openFDA NDC · 83027-0154 · Verified 2026-10-09 · open in source
ingredients.0 · openFDA NDC · 83027-0154 · Verified 2026-10-09 · open in source
ingredients.1 · openFDA NDC · 83027-0154 · Verified 2026-10-09 · open in source
ingredients.2 · openFDA NDC · 83027-0154 · Verified 2026-10-09 · open in source
ingredients.3 · openFDA NDC · 83027-0154 · Verified 2026-10-09 · open in source
ingredients.4 · openFDA NDC · 83027-0154 · Verified 2026-10-09 · open in source
ingredients.5 · openFDA NDC · 83027-0154 · Verified 2026-10-09 · open in source
ingredients.6 · openFDA NDC · 83027-0154 · Verified 2026-10-09 · open in source
ingredients.7 · openFDA NDC · 83027-0154 · Verified 2026-10-09 · open in source
ingredients.8 · openFDA NDC · 83027-0154 · Verified 2026-10-09 · open in source